Transforming vaccine development and drug discovery
Vaxine Pty Ltd is a leading Australian biotechnology company dedicated to transforming vaccine development and drug discovery. Based in Adelaide, South Australia, Vaxine Pty Ltd is focused on creating a robust pipeline of innovative vaccines targeting infectious diseases, allergies, and cancer. The company operates from its primary address at Flinders Medical Centre, Bedford Park, Adelaide, South Australia 5042, AU.
Vaxine Pty Ltd has pioneered the Advax range of proprietary polysaccharide adjuvants, a state-of-the-art technology that enhances vaccine efficacy. This advanced adjuvant technology is being applied to the development of vaccines against a wide array of critical diseases, including hepatitis B, pandemic influenza, Japanese encephalitis, West Nile virus, malaria, HIV, and rabies. Vaxine Pty Ltd is committed to advancing global health through cutting-edge research and development.
With a strong emphasis on innovation and scientific excellence, Vaxine Pty Ltd continues to expand its research efforts and collaborations. The company is dedicated to delivering effective and accessible vaccines to address unmet medical needs worldwide. We invite the manager of Vaxine Pty Ltd to create a customized and exclusive company showcase and product listing on our platform to further amplify their reach and impact.
Vaxine Pty Ltd est une entreprise australienne de biotechnologie de premier plan dédiée à la transformation du développement de vaccins et de la découverte de médicaments. Basée à Adélaïde, en Australie-Méridionale, Vaxine Pty Ltd se concentre sur la création d'un solide pipeline de vaccins innovants ciblant les maladies infectieuses, les allergies et le cancer. La société opère à partir de son adresse principale au Flinders Medical Centre, Bedford Park, Adélaïde, Australie-Méridionale 5042, AU.
Vaxine Pty Ltd a été le pionnier de la gamme Advax d'adjuvants polysaccharidiques exclusifs, une technologie de pointe qui améliore l'efficacité des vaccins. Cette technologie d'adjuvant avancée est appliquée au développement de vaccins contre un large éventail de maladies critiques, notamment l'hépatite B, la grippe pandémique, l'encéphalite japonaise, le virus du Nil occidental, le paludisme, le VIH et la rage. Vaxine Pty Ltd s'engage à faire progresser la santé mondiale grâce à la recherche et au développement de pointe.
Avec un fort accent sur l'innovation et l'excellence scientifique, Vaxine Pty Ltd continue de développer ses efforts de recherche et ses collaborations. L'entreprise se consacre à la fourniture de vaccins efficaces et accessibles pour répondre aux besoins médicaux non satisfaits dans le monde entier. Nous invitons le responsable de Vaxine Pty Ltd à créer une vitrine d'entreprise et une liste de produits personnalisées et exclusives sur notre plateforme afin d'amplifier davantage leur portée et leur impact.
Compare Vaxine Pty Ltd with 3 companies in Biotechnology-Research
| Comparison Field |
Vaxine Pty LtdMain Company |
Jenner InstituteView Profile |
Research Associates...View Profile |
AgonOx, Inc.View Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 2005 | 2012 | |
|
Company Size
|
— | 51-200 | 2-10 | 2-10 |
|
City
|
Adelaide, South Australia | Oxford, Please Select State | Coral Gables, Florida | Portland, Oregon |
|
Country
|
Australia | United States | United States | United States |
|
Skills & Keywords
Comparing with main company
|
15 Total Skills
Biotechnology
Vaccine Development
Drug Discovery
Immunology
Infectious Diseases
Vaccine Adjuvants
Cancer Immunotherapy
Cancer immunotherapy
Vaccine clinical trials
Vaccine adjuvants
Artificial intelligence
Vaccine development
Influenza
Drug design
Allergy
|
1 Total
1 Unique
Unique Skills:
Clinical Trials
|
8 Total
8 Unique
Unique Skills:
Clinical Research
Dermatology
Gastroenterology
Hepatology
Obesity
Pain Management
+2
|
6 Total
6 Unique
Unique Skills:
Cancer research
Combination treatments
Drug discovery
Immune phenotyping
Oncology
T cell based immunotherapy
|
Other organizations in the same industry
This company is also known as